All articles by Abigail Beaney

Abigail Beaney

Abigail Beaney is a pharmaceutical reporter for the Clinical Trials Arena. Abigail holds a BA (Hons) in Journalism from the University of Central Lancashire. Abigail has an expertise in trial design, cell and gene therapies and neurodegenerative diseases. Contact Abigail

Rising Sirturo resistance highlights urgent need for new TB therapies

There have been widespread reports that more effort and funding is needed to combat the TB crisis. As more cases…
Roche’s discontinued Alzheimer’s drug shows signs of preventing onset

Roche’s discontinued Alzheimer’s disease drug has shown signs that it could prevent onset of the disease. The Phase II/III Knight…
J&J drops Phase III MDD programme due to lack of efficacy

Johnson & Johnson (J&J) is dropping its Phase III major depressive disorder (MDD) programme for aticaprant due to ‘insufficient efficacy…
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial

Tris Pharma has reported another Phase III win with its investigational pain therapy, cebranopadol, and it is now setting up…
USAID: sponsors, agencies and foundations may have to fill funding gap

A shutdown of funding for the US Agency for International Development (USAID) could lead to the termination of clinical trials…

OCT West Coast 2025: Recruitment and regulation remain pain points

A packed agenda at Arena International’s Outsourcing in Clinical Trials (OCT) West Coast 2025 conference, which took place at the…
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts

Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at…
OCT West Coast 2025: China surpasses US for annual number of clinical trials

China has seen a rise in ongoing clinical trials for the past few years which has now surpassed the US,…
Be realistic, responsive and transparent: how to engage underperforming sites

Being realistic, responsive and transparent is key in engaging unresponsive and underperforming clinical trial sites; that was the takeaway from…
RFK Jr. thrusts domestic manufacturing agenda on Day 2 of confirmation hearings

Robert F. Kennedy Jr. (RFK Jr) has claimed that “China will be able to ransom medical health” in America due…